一般演題採択演題

27.Cardiovascular pharmacology (clinical)
Receipt no.First nameLast nameAbstract title
10149ToshiharuFujiiImpact of Beta Blocker Dose on Left Ventricular Ejection Fraction Following Primary Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction
10241YusukeYoshikawaIncidence and Impact of Dual Antiplatelet Therapy (DAPT) Cessation on Adverse Events after Percutaneous Coronary Intervention (PCI)
10393TakaakiShionoShorting the period of Triple Anti-platelet and Anti-coagulation therapy after Coronary Stenting, STAP trial
10768HirokazuSanoTherapeutic Effects of Statin on Sympathetic Nerve Activity and Cardiac Events in Chronic Heart Failure Patients with Old Myocardial Infarction
11364HisaoOtsukiReal-world Practice of Novel Oral Anticoagulant and Antiplatelet Therapy in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: A Multi-center Registry
12153MasahiroKoenACEI Insufficiently Suppresses Aldosterone Secretion Compared with ARB in Patients with Acute Myocardial Infarction
12625MikikoHaradaLong Term Prediction of Clinical Adverse Effects of Beta-Blocker for Patients with Peripheral Arterial Disease.
12867TaikiKinjoRelationships between Urate-Lowering Pharmacotherapy and Cardiovascular Events in Patients with Hyperuricemia in a Hospital Cohort
12885YuichiroArimaA Novel Flow-Chamber System for Quantitative Assessment of Whole Blood Thrombogenicity in Coronary Artery Disease Patients with Antiplatelet Therapies
12940KenichiTsujitaImpact of Statin-Ezetimibe Combination on Coronary Atheroma Progression/Regression in Patients with and without Statin Pretreatment- Subanalysis of PRECISE-IVUS Trial -
13298KenichiTokutakeDoes the Infusion Site have an Influence on Pharmacological Action of Adenosine Triphosphate?
13421YusukeMiyazakiStatins can not Improve Left Ventricular Diastolic Dysfunction but Decrease Oxidative Modified Low Density Lipoproteins
13725HisatoItoThe Effectiveness of Tolvaptan in Postoperative Fluid Management for the Patients Undergoing Open Heart Surgery
20019Soon JunHongAnti-Platelet Effects of Epigallocatechin-3-Gallate in Addition to the Concomitant Aspirin, Clopidogrel or Ticagrelor Treatment

PAGE TOP